Авторы

  • Турабов А.З., Юнусова З.Д.

Ключевые слова:

миелодиспластический синдром, перегрузка железом, ферритин, сывороточное железо, переливание крови, ферротерапия.

Библиографические ссылки

Cakar MK, Yegin ZA, Baysal NA, et al. Adverse impact of hyperferritinemia and transfusion dependency on treatment success in myelodysplastic syndrome. Transfus Apher Sci. 2013; 48: 397 – 401.

Goldberg S.L. et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. // J. Clin. Oncol. 2010. Vol. 28, № 17. P. 2847–2852.

Greenberg P.L. et al. Revised international prognostic scoring system for myelodysplastic syndromes // Blood. 2012. Vol. 120, № 12. P. 2454–2465

Kikuchi S, Kobune M, Iyama S, et al. Prognostic significance of serum ferritin concentration at diagnosis in myelodysplastic syndrome. Int J Hematol. 2012; 95: 527– 534.

"Myelodysplastic Syndromes Treatment (PDQ®)–Patient Version". NCI. 12 August 2015. Archived from the original on 5 October 2016. Retrieved 27 October 2016.

Mufti G.J. et al. Diagnosis and classification of myelodysplastic syndrome: International 67 Working Group on Morphology of myelodysplastic syndrome (IWGM–MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. // Haematologica. 2008. Vol. 93, № 11. P. 1712–1717

Pilo, F., Di Tucci, A. A., Dessalvi, P., Caddori, A., & Angelucci, E. (2010). The evolving clinical scenario of myelodysplastic syndrome: The need for a complete and up to date upfront diagnostic assessment. European Journal of Internal Medicine, 21(6), 490–495. doi:10.1016/j.ejim.2010.09.003

Seguier J. et al. Autoimmune diseases in myelodysplastic syndrome favors patient’s survival: A case control study and literature review. // Autoimmun. Rev. 2019. Vol. 18, № 1. P. 36–42

Shenoy N, Vallumsetla N, Rachmilewitz E, Verma A, Ginzburg Y Impact of iron overload and potential benefit from iron chelation in low–risk myelodysplastic syndrome. Blood. 2014; 124: 873 – 881.

Swerdlow S.H. et al. WHO classification of tumors of hematopoietic and lymphoid tissues. Revised 4th ed. Lyon, France: International Agency for Research in Cancer (IARC) / ed. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H T.J. 2017. 585p.

Wong, C. A. C., Wong, S. A. Y., & Leitch, H. A. (2018). Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy. Leukemia Research, 67, 75–81. doi:10.1016/j.leukres.2018.02.